…nd significantly reducing or terminating investments into others. Examples of this type of investment include Intarcia Therapeutics (NLV-I) and Synageva Biopharma (NLV-II, reverse merger to become public - November, 2011, NASDAQ: GEVA,; exi...
Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction
IMAGES-007-HOUSE_OVERSIGHT_024045.txt
p.1
View source release ↗